IUCRO-0042; Blood Drawing for Study of Peripheral Blood T-Lymphocytes and Other Parameters in patients with Metastatic Melanoma and Renal Cell Cancer with Spontaneous Regression
The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression in order to study immune response.
The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.
- IRB Number: 1011003667 (0301-66)
- Research Study Identifier: TX1000
- Principal Investigator: Theodore Logan, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required